Clinical Trial Update: Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial examined the effect of exenatide on determinants of glucose homeostasis in type 2 diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exenatide (Byetta) (exenatide)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED